@FiercePharma: Union urges votes against CEO pay at Pfizer, J&J. News | Follow @FiercePharma
> Shanghai Pharmaceuticals, one of China's biggest medicine companies, said it will ink more than 20 billion yuan ($3.06 billion) worth of procurement contracts with 69 multinational pharmaceutical companies this year. News
> Elliott Advisors, the biggest shareholder in Actelion, offered a partial olive branch to the Swiss biotech group by supporting its nomination of two new independent board members, including former GlaxoSmithKline CEO Jean-Pierre Garnier. Report
> Watson Pharmaceuticals will move its corporate headquarters to Parsippany, New Jersey from Corona, California. Item
> India's No. 2 drugmaker Dr. Reddy's Laboratories launched its over-the-counter Fexofenadine HCl tablets, a generic version of Sanofi Aventis' antihistamine drug Allegra. Article
> UK household-goods and consumer health company Reckitt Benckiser said Rakesh Kapoor will take over as CEO in September, replacing Bart Becht, who has quit after 16 years at the helm. Story
> The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation, issued "informal guidance" on digital communications, and while it's more than FDA has offered, it's not much to go on. Item
> New York Gov. Andrew Cuomo has signed into law a bill enabling OSI Pharmaceuticals to expand at Farmingdale State College. Report
> Bulgarian pharmaceuticals maker Sopharma has acquired the Belorussian pharmacy chain Tabina through its Latvian unit Briz. Article
> The New York Pharma Forum, a non-profit association for biopharmaceutical corporations, announced the election of Blaine McKee, SVP at Genzyme, as its president. NYPF release
Biotech News
@FierceBiotech: Burrill: Pharma's M&A strategy has failed. News | Follow @FierceBiotech
> Regulus, UC San Diego team on microRNA. Story
> Nasal vaccines could replace shots. Article
> RegeneRx sets sights on dry-eye treatment. News
> Does Eisai's epilepsy drug work? Yes and no. Report
> Merrimack raises $77M for cancer work. News
> Plasticell spins out regenerative medicine company. Item
Vaccines News
> Personalized cancer vax shows promise against glioblastomas in study. Report
> Nasal vaccines could replace flu, pneumonia shots. Item
> HPV vax effective after longer dosing schedule. Article
> Army researchers start ricin vaccine trial. News
> PATH calls for cheaper, more effective pneumococcal vaccines. Story
Manufacturing News
> API crystals foul Hospira cancer drug. Item
> Ex-QC inspector alleges H&P/Triad plant violations. Report
> COO search marks Triad/H&P effort on raided plant. News
> FDA's OK of Perrigo plant signals SOP fixes. Item
And Finally... A new multiple sclerosis study debunks a theory about a potential cause for the disease, which had led patients to seek risky surgeries to unblock neck veins when drug treatments didn't work for them. Report